The synthesis and study of side-chain lactam-bridged peptides.
暂无分享,去创建一个
[1] P. Schiller,et al. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers. , 1985, Journal of medicinal chemistry.
[2] A. Piserchio,et al. Characterization of parathyroid hormone/receptor interactions: structure of the first extracellular loop. , 2000, Biochemistry.
[3] Thomas J. Allen,et al. THE STRUCTURE AND ENERGETICS OF HELIX FORMATION BY SHORT TEMPLATED PEPTIDES IN AQUEOUS SOLUTION. 3. CALCULATION OF THE HELICAL PROPAGATION CONSTANT S FROM THE TEMPLATE STABILITY CONSTANTS T/C FOR AC-HEL1-ALAN-OH, N = 1-6 , 1996 .
[4] V. Hruby. Design in topographical space of peptide and peptidomimetic ligands that affect behavior. A chemist's glimpse at the mind--body problem. , 2001, Accounts of chemical research.
[5] R. L. Baldwin,et al. Calorimetric determination of the enthalpy change for the alpha-helix to coil transition of an alanine peptide in water. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] Robert S. McDowell,et al. A General Method for Constraining Short Peptides to an α-Helical Conformation , 1997 .
[7] John W. Taylor,et al. Head-to-tail cyclization and use of Cα-allyl ester protection improves the yield of cyclic peptides synthesized by the oxime resin method , 1993 .
[8] A. Otaka,et al. Trimethylsilyl trifluoromethanesulphonate as a useful deprotecting reagent in both solution and solid phase peptide syntheses , 1987 .
[9] J. Rizo,et al. Constrained peptides: models of bioactive peptides and protein substructures. , 1992, Annual review of biochemistry.
[10] P. S. Kim,et al. HIV Entry and Its Inhibition , 1998, Cell.
[11] Christos,et al. Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Whitfield,et al. Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: cyclic lactams of the receptor binding region. , 1997, Journal of medicinal chemistry.
[13] J. Baldwin. The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.
[14] D. Braddock,et al. Structural and thermodynamic characterization of a bioactive peptide model of apolipoprotein E: side-chain lactam bridges to constrain the conformation. , 1994, Biochemistry.
[15] J. W. Taylor,et al. The structural characterization of beta-endorphin and related peptide hormones and neurotransmitters. , 1986, Pharmacological reviews.
[16] John W. Taylor,et al. Multicyclic polypeptide model compounds. 2. Synthesis and conformational properties of a highly .alpha.-helical uncosapeptide constrained by three side-chain to side-chain lactam bridges , 1992 .
[17] Design of a peptide hormone: synthesis and characterization of a model peptide with calcitonin-like activity , 1983 .
[18] E. Giralt,et al. Solution versus solid‐phase cyclization strategies for large sidechain lactam‐bridged peptides: A comparative study , 1995, Journal of peptide science : an official publication of the European Peptide Society.
[19] L. Suva,et al. Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Kaiser,et al. Amphiphilic secondary structure: design of peptide hormones. , 1984, Science.
[21] E. Kaiser,et al. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.
[22] John W. Taylor,et al. Synthesis and study of peptides with semirigid i and i+7 side-chain bridges designed for α-helix stabilization , 1999 .
[23] J. W. Taylor,et al. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues. , 1995, Journal of medicinal chemistry.
[24] R. Hodges,et al. Metal Ion Induced Folding of a de Novo Designed Coiled-Coil Peptide , 1998 .
[25] T. Ganz. Chemistry: Rings of destruction , 2001, Nature.
[26] A Fournier,et al. Synthesis, biological activity and conformational analysis of cyclic GRF analogs. , 2009 .
[27] Henry I. Mosberg. Complementarity of δ opioid ligand pharmacophore and receptor models , 1999 .
[28] R. Campbell,et al. Solution structures of cyclic and dicyclic analogues of growth hormone releasing factor as determined by two‐dimensional NMR and CD spectroscopies and constrained molecular dynamics , 1992, Biopolymers.
[29] H. Kessler,et al. 2-(2-pyridyl-)ethyl esters A new carboxyl protecting group in peptide synthesis , 1984 .
[30] R. Epand,et al. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions. , 1996, Endocrinology.
[31] W. DeGrado,et al. The helix-forming propensity of D-alanine in a right-handed .alpha.-helix , 1992 .
[32] V J Hruby,et al. Conformational restrictions of biologically active peptides via amino acid side chain groups. , 1982, Life sciences.
[33] S. Lahrichi,et al. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Mammi,et al. Aib-rich peptides containing lactam-bridged side chains as models of the 3(10)-helix. , 2001, Journal of the American Chemical Society.
[35] M. Ghadiri,et al. Peptide architecture. Design of stable .alpha.-helical metallopeptides via a novel exchange-inert ruthenium(III) complex , 1990 .
[36] John W. Taylor,et al. Multicyclic polypeptide model compounds. 1. Synthesis of a tricyclic amphiphilic .alpha.-helical peptide using an oxime resin, segment-condensation approach , 1990 .
[37] R. Campbell,et al. Rational design, synthesis, and biological evaluation of novel growth hormone releasing factor analogues , 1995, Biopolymers.
[38] R. Hodges,et al. Use of a conformationally restricted secondary structural element to display peptide libraries: a two-stranded alpha-helical coiled-coil stabilized by lactam bridges. , 1996, Journal of molecular biology.
[39] H. Kunz,et al. 2-(Pyridyl)ethyl Esters as Secure yet Readily Removable Polarophilic Carboxy-Protection in Peptide Synthesis†‡ , 1984 .
[40] David P. Fairlie,et al. The First Solution Stucture of a Single α-Helical Turn. A Pentapeptide α-Helix Stabilized by a Metal Clip , 2000 .
[41] R. Hodges,et al. Contribution of Translational and Rotational Entropy to the Unfolding of a Dimeric Coiled-Coil , 1999 .
[42] P. Schiller,et al. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists. , 1999, Biopolymers.
[43] Peter W. Schiller,et al. Opiate receptor subclasses differ in their conformational requirements , 1982, Nature.
[44] S. S. Isied,et al. Peptide formation in the presence of a metal ion protecting group. 4. Synthesis of penta- and hexapeptide sequences with the pentaamminecobalt(III) complex , 1982 .
[45] I. Morize,et al. The Bioactive Conformation of Human Parathyroid Hormone. Structural Evidence for the Extended Helix Postulate , 2000 .
[46] J. W. Taylor,et al. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues. , 1999, European journal of biochemistry.
[47] H. Rink. Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin. , 1987 .
[48] Wentao Zhang,et al. Efficient solid-phase synthesis of peptides with tripodal side-chain bridges and optimization of the solvent conditions for solid-phase cyclizations , 1996 .
[49] G. Fields,et al. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.
[50] L. J. Perry,et al. Disulfide bonds and thermal stability in T4 lysozyme. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[51] Juan R. Granja,et al. Self-assembling organic nanotubes based on a cyclic peptide architecture , 1993, Nature.
[52] R. S. Spolar,et al. Coupling of local folding to site-specific binding of proteins to DNA. , 1994, Science.
[53] R. Edwards,et al. Cloning of a delta opioid receptor by functional expression. , 1992, Science.
[54] D. Wemmer,et al. Structure of P401 (mast cell degranulating peptide) in solution. , 1988, Biophysical chemistry.
[55] John W. Taylor,et al. A new strategy applied to the synthesis of an α-helical bicyclic peptide constrained by two overlapping i, i+7 side-chain bridges of novel design , 1996 .
[56] M. Ghadiri,et al. Secondary structure nucleation in peptides. Transition metal ion stabilized .alpha.-helices , 1990 .
[57] J. V. Aldrich,et al. Side-product formation during cyclization with HBTU on a solid support. , 2009, International journal of peptide and protein research.
[58] Clay Bracken,et al. SYNTHESIS AND NUCLEAR MAGNETIC RESONANCE STRUCTURE DETERMINATION OF AN ALPHA -HELICAL, BICYCLIC, LACTAM-BRIDGED HEXAPEPTIDE , 1994 .
[59] T. Matthews,et al. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. B. Merrifield,et al. Mechanisms for the removal of benzyl protecting groups in synthetic peptides by trifluoromethanesulfonic acid-trifluoroacetic acid-dimethyl sulfide , 1986 .
[61] The Effect of C‐Terminal Helix Stabilization on Specific DNA Binding by Monomeric GCN4 Peptides , 2002, Journal of peptide science : an official publication of the European Peptide Society.
[63] W. DeGrado,et al. A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. , 1990, Science.
[64] Peter G. Schultz,et al. General approach to the synthesis of short .alpha.-helical peptides , 1991 .
[65] P. Grieco,et al. Preparation of 'side-chain-to-side-chain' cyclic peptides by Allyl and Alloc strategy: potential for library synthesis. , 2001, The journal of peptide research : official journal of the American Peptide Society.
[66] A. Satterthwait,et al. A role for amino acids in the cooperative interactions between an alpha helix nucleation site and appended peptides , 1994 .
[67] R. L. Baldwin,et al. Mechanism of helix induction by trifluoroethanol: a framework for extrapolating the helix-forming properties of peptides from trifluoroethanol/water mixtures back to water. , 1997, Biochemistry.
[68] T. Matthews,et al. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. , 1995, AIDS research and human retroviruses.
[69] D. Wemmer,et al. Solution structure of apamin determined by nuclear magnetic resonance and distance geometry. , 1988, Biochemistry.
[70] S. Harrison,et al. Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.
[71] G. Makhatadze,et al. Heat capacity changes upon burial of polar and nonpolar groups in proteins , 2001, Protein science : a publication of the Protein Society.
[72] Arnold C. Satterthwait,et al. The Hydrogen Bond Mimic Approach: Solid-Phase Synthesis of a Peptide Stabilized as an α-Helix with a Hydrazone Link , 1999 .
[73] J. Baum,et al. Conformational characterization of a helix-nucleated bicyclic GCN4 decapeptide by proton NMR. , 2000, The journal of peptide research : official journal of the American Peptide Society.
[74] E. Arnold,et al. Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5: effects of side-chain and backbone modifications and conformational constraints. , 2002, The journal of peptide research : official journal of the American Peptide Society.
[75] J. Kelly,et al. The nucleation of monomeric parallel beta-sheet-like structures and their self-assembly in aqueous solution. , 1999, Bioorganic & medicinal chemistry.
[76] P. Privalov,et al. A calorimetric study of the folding-unfolding of an alpha-helix with covalently closed N and C-terminal loops. , 1999, Journal of molecular biology.
[77] G Himmler,et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 , 1993, Journal of virology.
[78] H. Scheraga,et al. Influence of an extrinsic cross-link on the folding pathway of ribonuclease A. Conformational and thermodynamic analysis of cross-linked (lysine7-lysine41)-ribonuclease a. , 1984, Biochemistry.
[79] Juan R. Granja,et al. Antibacterial agents based on the cyclic d,l-α-peptide architecture , 2001, Nature.
[80] F. Guibé. Allylic protecting groups and their use in a complex environment part II: Allylic protecting groups and their removal through catalytic palladium π-allyl methodology , 1998 .
[81] D. Kemp,et al. High Helicities of Lys-Containing, Ala-Rich Peptides Are Primarily Attributable to a Large, Context-Dependent Lys Stabilization , 1998 .
[82] M. Chorev,et al. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor. , 2000, Biochemistry.
[83] A. Otaka,et al. New strategy for the chemical synthesis of proteins , 1988 .
[84] E. Stellwagen,et al. Analysis of the Thermal Transitions of a Model Helical Peptide Using 13C NMR , 1994 .
[85] A. Motta,et al. A 1H NMR study of human calcitonin in solution. , 1991, Biochemistry.
[86] T. Muir,et al. Rescuing a destabilized protein fold through backbone cyclization. , 2001, Journal of molecular biology.
[87] J. Nowick,et al. Two New β-strand Mimics , 1999 .
[88] J. Becker,et al. Conformational analysis of cyclic analogues of the Saccharomyces cerevisiae alpha-factor pheromone. , 1998, Biopolymers.
[89] R. Epand,et al. Presence of an amphipathic helical segment and its relationship to biological potency of calcitonin analogs. , 2009, International journal of peptide and protein research.
[90] M. Scheideler,et al. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues. , 2002, Journal of Medicinal Chemistry.
[91] Thomas J. Allen,et al. The Structure and Energetics of Helix Formation by Short Templated Peptides in Aqueous Solution. 2. Characterization of the Helical Structure of Ac-Hel1-Ala6-OH , 1996 .
[92] R. Hodges,et al. Lactam bridge stabilization of α‐helical peptides: Ring size, orientation and positional effects , 1995 .
[93] V. Hruby,et al. A new approach to search for the bioactive conformation of glucagon: positional cyclization scanning. , 2001, Journal of medicinal chemistry.
[94] Scott T. Phillips,et al. “@-Tides”: The 1,2-Dihydro-3(6H)-pyridinone Unit as a β-Strand Mimic , 2002 .
[95] M. Azria. The Calcitonins: Physiology and Pharmacology , 1989 .
[96] Synthesis of four diastereomeric enkephalins incorporating cyclopropyl phenylalanine. , 2009, International journal of peptide and protein research.
[97] M. Hearn,et al. Solid phase synthesis of cyclic peptides: model studies involving i−(i+4) side chain‐to‐side chain cyclisation , 1998 .
[98] M. Chorev,et al. Cyclic parathyroid hormone related protein antagonists: lysine 13 to aspartic acid 17 [i to (i + 4)] side chain to side chain lactamization. , 1991, Biochemistry.
[99] A. Lomize,et al. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. , 1998, Biophysical journal.
[100] D. Ferguson,et al. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation. , 1997, Journal of medicinal chemistry.
[101] B. Olivera,et al. The T-superfamily of Conotoxins* , 1999, The Journal of Biological Chemistry.